Renal failure and disease are critical health issues that profoundly impact medication therapy management. Pharmacists must possess a deep understanding of both Acute Kidney Injury (AKI) and the progressive nature of Chronic Kidney Disease (CKD), as detailed in the Patient Care 4 curriculum’s comprehensive “Renal System” module. This quiz will test your knowledge on the pathophysiology, staging, and evidence-based management of various renal diseases and their myriad complications, preparing you for this vital area of pharmacy practice.
1. An abrupt decline in kidney function characterized by a rise in serum creatinine and/or a decrease in urine output is known as:
- a. Chronic Kidney Disease (CKD)
- b. End-Stage Renal Disease (ESRD)
- c. Acute Kidney Injury (AKI)
- d. Nephrotic Syndrome
Answer: c. Acute Kidney Injury (AKI)
2. Which type of AKI is caused by a sudden drop in blood flow to the kidneys?
- a. Prerenal
- b. Intrinsic
- c. Postrenal
- d. Intrarenal
Answer: a. Prerenal
3. The two most common causes of Chronic Kidney Disease (CKD) in the United States are:
- a. Smoking and hyperlipidemia
- b. Diabetes and hypertension
- c. Polycystic kidney disease and glomerulonephritis
- d. Recurrent kidney stones and infections
Answer: b. Diabetes and hypertension
4. According to the KDIGO guidelines, CKD is staged based on the patient’s GFR and what other laboratory marker?
- a. Serum potassium
- b. Hemoglobin
- c. Albuminuria
- d. Serum phosphate
Answer: c. Albuminuria
5. Which class of medications is recommended first-line to slow the progression of diabetic kidney disease, particularly in patients with albuminuria?
- a. Beta-blockers
- b. Calcium channel blockers
- c. ACE Inhibitors or ARBs
- d. Loop diuretics
Answer: c. ACE Inhibitors or ARBs
6. The “Pathophysiology and Management of Acute Kidney Injury (AKI)” is a specific learning module in which course?
- a. PHA5784C Patient Care 4
- b. PHA5104 Sterile Compounding
- c. PHA5703 Pharmacy Law and Ethics
- d. PHA5878C Patient Care 3
Answer: a. PHA5784C Patient Care 4
7. Anemia of CKD is primarily caused by a deficiency of:
- a. Iron
- b. Vitamin B12
- c. Erythropoietin (EPO)
- d. Folic acid
Answer: c. Erythropoietin (EPO)
8. Before initiating an erythropoiesis-stimulating agent (ESA) for anemia of CKD, the pharmacist must ensure the patient has:
- a. Adequate iron stores.
- b. A very high hemoglobin level.
- c. Uncontrolled blood pressure.
- d. A low serum potassium level.
Answer: a. Adequate iron stores.
9. Acute Tubular Necrosis (ATN) caused by a nephrotoxic drug like an aminoglycoside is what type of AKI?
- a. Prerenal
- b. Intrinsic
- c. Postrenal
- d. Functional
Answer: b. Intrinsic
10. A patient with an enlarged prostate causing a urinary obstruction develops an AKI. This is classified as:
- a. Prerenal
- b. Intrinsic
- c. Postrenal
- d. Vasomotor
Answer: c. Postrenal
11. The “Pathophysiology and Management of Chronic Kidney Disease (CKD)” is a topic covered in the Patient Care 4 curriculum.
- a. True
- b. False
Answer: a. True
12. The management of CKD-Mineral and Bone Disorder (CKD-MBD) involves:
- a. Lowering serum phosphate with phosphate binders.
- b. Managing secondary hyperparathyroidism with Vitamin D analogs or calcimimetics.
- c. Maintaining calcium homeostasis.
- d. All of the above.
Answer: d. All of the above.
13. A patient is prescribed sevelamer for hyperphosphatemia. The pharmacist should counsel the patient to take this medication:
- a. On an empty stomach.
- b. With meals to bind dietary phosphate.
- c. At bedtime.
- d. Once a week.
Answer: b. With meals to bind dietary phosphate.
14. Which of the following is an “alarm symptom” in a patient at risk for AKI?
- a. Normal urine output.
- b. A sudden, significant decrease in urine output (oliguria).
- c. Mild fatigue.
- d. A stable serum creatinine.
Answer: b. A sudden, significant decrease in urine output (oliguria).
15. How do NSAIDs cause drug-induced kidney disease?
- a. They cause vasodilation of the efferent arteriole.
- b. They cause direct tubular necrosis.
- c. They inhibit prostaglandin synthesis, leading to vasoconstriction of the afferent arteriole.
- d. They cause an allergic reaction in the interstitium.
Answer: c. They inhibit prostaglandin synthesis, leading to vasoconstriction of the afferent arteriole.
16. The “Management of Drug-Induced Kidney Disease” is an active learning session in the Patient Care 4 course.
- a. True
- b. False
Answer: a. True
17. What is the GFR range for Stage 5 CKD (End-Stage Renal Disease)?
- a. > 90 mL/min/1.73m²
- b. 60-89 mL/min/1.73m²
- c. 30-59 mL/min/1.73m²
- d. < 15 mL/min/1.73m²
Answer: d. < 15 mL/min/1.73m²
18. The cornerstone of management for prerenal AKI is:
- a. Starting a potent diuretic.
- b. Restoring renal perfusion with IV fluids or by treating the underlying cause of hypoperfusion.
- c. Initiating dialysis immediately.
- d. Administering an NSAID.
Answer: b. Restoring renal perfusion with IV fluids or by treating the underlying cause of hypoperfusion.
19. A patient with CKD is at high risk for which electrolyte abnormality?
- a. Hypokalemia
- b. Hyperkalemia
- c. Hypophosphatemia
- d. Hypernatremia
Answer: b. Hyperkalemia
20. The curriculum includes a module on the “Renal System” in Patient Care 4.
- a. True
- b. False
Answer: a. True
21. Acute Interstitial Nephritis (AIN) is a type of intrinsic AKI most often caused by:
- a. Dehydration
- b. A hypersensitivity reaction to a drug (e.g., a beta-lactam or PPI).
- c. An enlarged prostate.
- d. Sepsis.
Answer: b. A hypersensitivity reaction to a drug (e.g., a beta-lactam or PPI).
22. Which of the following is NOT a primary goal of CKD management?
- a. Curing the kidney disease.
- b. Slowing the progression of kidney damage.
- c. Managing comorbidities like hypertension and diabetes.
- d. Treating complications like anemia and CKD-MBD.
Answer: a. Curing the kidney disease.
23. Why is it important to adjust the doses of many medications in patients with renal failure?
- a. To increase their effectiveness.
- b. To prevent the accumulation of the drug or its metabolites, leading to toxicity.
- c. Because all drugs are cleared by the kidneys.
- d. To make the drugs cheaper.
Answer: b. To prevent the accumulation of the drug or its metabolites, leading to toxicity.
24. An active learning session on AKI and CKD is part of the Patient Care 4 curriculum.
- a. True
- b. False
Answer: a. True
25. A patient with diabetic nephropathy is started on lisinopril. A small, initial increase in serum creatinine (e.g., up to 30%) is:
- a. A sign of acute renal failure requiring immediate discontinuation of the drug.
- b. An expected hemodynamic effect that indicates the drug is working to reduce glomerular pressure.
- c. A reason to double the dose of lisinopril.
- d. An indication for starting dialysis.
Answer: b. An expected hemodynamic effect that indicates the drug is working to reduce glomerular pressure.
26. Which of the following is a symptom of uremia in a patient with ESRD?
- a. High energy levels
- b. Nausea, fatigue, and metallic taste
- c. Increased appetite
- d. Normal skin color
Answer: b. Nausea, fatigue, and metallic taste
27. The primary treatment for postrenal AKI is:
- a. IV fluids
- b. Diuretics
- c. Relieving the source of the obstruction.
- d. An ACE inhibitor.
Answer: c. Relieving the source of the obstruction.
28. An active learning session on the renal system is part of which course?
- a. PHA5784C Patient Care 4
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient care 2
Answer: a. PHA5784C Patient Care 4
29. ESAs like epoetin alfa should not be initiated until the hemoglobin is below what level in CKD patients?
- a. 13 g/dL
- b. 12 g/dL
- c. 11 g/dL
- d. 10 g/dL
Answer: d. 10 g/dL
30. The “Dosing in Renal Dysfunction” is a core module in the Drug Therapy Individualization course.
- a. True
- b. False
Answer: a. True
31. A patient with CKD and hyperkalemia should be counseled to avoid:
- a. High-potassium foods like bananas and oranges.
- b. Salt substitutes containing potassium chloride.
- c. NSAIDs.
- d. All of the above.
Answer: d. All of the above.
32. What is the definition of microalbuminuria?
- a. Urine albumin-to-creatinine ratio (UACR) < 30 mg/g
- b. UACR 30-300 mg/g
- c. UACR > 300 mg/g
- d. No albumin in the urine.
Answer: b. UACR 30-300 mg/g
33. What is the role of a pharmacist in preventing drug-induced kidney disease?
- a. Screening for high-risk patients and high-risk drugs.
- b. Recommending appropriate hydration.
- c. Monitoring renal function during therapy with nephrotoxic agents.
- d. All of the above.
Answer: d. All of the above.
34. The term “nephrotoxic” refers to a substance that is:
- a. Beneficial to the kidneys.
- b. Excreted by the kidneys.
- c. Toxic or damaging to the kidneys.
- d. Metabolized by the kidneys.
Answer: c. Toxic or damaging to the kidneys.
35. A patient with CKD Stage 4 has:
- a. Normal kidney function.
- b. Mildly decreased kidney function.
- c. Moderately decreased kidney function.
- d. Severely decreased kidney function.
Answer: d. Severely decreased kidney function.
36. A patient is receiving IV contrast for a CT scan. A preventative strategy for contrast-induced nephropathy is:
- a. Administering an NSAID before the scan.
- b. Restricting fluids.
- c. IV hydration with normal saline before and after the scan.
- d. Administering a diuretic after the scan.
Answer: c. IV hydration with normal saline before and after the scan.
37. Which of the following is NOT a complication of CKD?
- a. Anemia
- b. Mineral and Bone Disorder
- c. Cardiovascular Disease
- d. Improved medication clearance
Answer: d. Improved medication clearance
38. The principle of renal clearance is a major topic in the Drug Therapy Individualization course.
- a. True
- b. False
Answer: a. True
39. Management of a patient with AKI includes:
- a. Discontinuing all potentially nephrotoxic medications.
- b. Adjusting the doses of all renally cleared medications.
- c. Monitoring fluid status and electrolytes closely.
- d. All of the above.
Answer: d. All of the above.
40. An active learning session covering AKI and CKD is part of which course module?
- a. Module 7: Renal System
- b. Module 1: PUD and GERD
- c. Module 4: Gastrointestinal Infections
- d. Module 5: Nutrition & Weight Management
Answer: a. Module 7: Renal System
41. The most common cause of intrinsic AKI in hospitalized patients is:
- a. Glomerulonephritis
- b. Acute Interstitial Nephritis (AIN)
- c. Acute Tubular Necrosis (ATN)
- d. Vasculitis
Answer: c. Acute Tubular Necrosis (ATN)
42. Which of the following can cause prerenal AKI?
- a. Sepsis leading to hypotension.
- b. Heart failure with low cardiac output.
- c. Severe volume depletion from vomiting.
- d. All of the above.
Answer: d. All of the above.
43. The progression of CKD can be slowed by:
- a. Strict blood pressure control.
- b. Strict glycemic control in diabetic patients.
- c. Use of ACE inhibitors or ARBs in patients with proteinuria.
- d. All of the above.
Answer: d. All of the above.
44. A patient is taking metformin and their eGFR drops to 25 mL/min/1.73m². The pharmacist should recommend:
- a. Increasing the metformin dose.
- b. Continuing the current dose.
- c. Discontinuing the metformin.
- d. Adding a second diabetes medication.
Answer: c. Discontinuing the metformin.
45. Which of the following is a common cause of drug-induced acute interstitial nephritis (AIN)?
- a. Acetaminophen
- b. Penicillins and NSAIDs
- c. Digoxin
- d. Metformin
Answer: b. Penicillins and NSAIDs
46. End-Stage Renal Disease (ESRD) is defined as:
- a. CKD Stage 3
- b. CKD Stage 4
- c. CKD requiring dialysis or kidney transplantation.
- d. Any form of AKI.
Answer: c. CKD requiring dialysis or kidney transplantation.
47. A BUN:SCr ratio > 20:1 suggests:
- a. Postrenal obstruction
- b. A prerenal cause or dehydration
- c. Intrinsic kidney damage
- d. A normal state
Answer: b. A prerenal cause or dehydration
48. An active learning session on renal failure is part of which course?
- a. PHA5784C Patient Care 4
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5784C Patient Care 4
49. The presence of “muddy brown casts” in the urine is pathognomonic for:
- a. Acute Tubular Necrosis (ATN)
- b. Prerenal AKI
- c. Postrenal AKI
- d. Normal urine
Answer: a. Acute Tubular Necrosis (ATN)
50. The ultimate goal of understanding renal failure and disease is to:
- a. Memorize all the stages of CKD.
- b. Prevent, slow the progression of, and manage the complications of kidney disease through safe and effective medication therapy.
- c. Be able to dose all drugs without a calculator.
- d. Qualify to perform dialysis.
Answer: b. Prevent, slow the progression of, and manage the complications of kidney disease through safe and effective medication therapy.
